Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • Telephone

      • +972-77-2005042 from 8 AM - 11 PM IL

      • Contact
      • Contact

        +972-77-2005042
        from 8 AM - 11 PM IL

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Request More Information
      • Journalists
      • GDPR

      EFISHient Protein Announces Successful Development of Tilapia Cell Line


      News provided by

      EFISHient Protein

      09 Apr, 2024, 14:00 IDT

      Share this article

      Share this article


      EFISHient Protein, at the forefront of FoodTech innovation, achieves a breakthrough in Tilapia cell line development, revolutionizing the landscape of cultivated meat technology and driving sustainable fish production forward.

      TEL AVIV, Israel, April 9, 2024 /PRNewswire/ -- EFISHient Protein, a leading Israeli FoodTech company, proudly announces the successful completion of the Tilapia cell line development. This groundbreaking achievement signifies a significant advancement in the field of cultivated meat technology, paving the way for sustainable cultivated Fish Production.

      Continue Reading
      EFISHient Protein Tilapia Cell Line. Credit: Roee Shpernik
      EFISHient Protein Tilapia Cell Line. Credit: Roee Shpernik

      Through cutting-edge technological capabilities, EFISHient Protein has unlocked the potential to produce muscle and fat cells of Tilapia, a key step towards establishing a genetic cell bank. This milestone underscores EFISHient Protein's commitment to providing alternative protein solutions and promoting sustainable practices in the global fish products industry.

      Dana Levin, CEO of EFISHient Protein, expressed immense pride and excitement about this milestone, stating, "We are thrilled to lead the way in revolutionizing the global fish products industry. Completing the Tilapia cell line development showcases our dedication to accelerating sustainable protein solutions, ensuring future generations can enjoy nutritious and ethical fish products".

      EFISHient Protein's partnership with BioMeat Foodtech and the Volcani Institute has been instrumental in combining breakthrough technology with extensive experience in the alternative protein sector. This collaboration positions EFISHient Protein as a promising player in the cultivated fish industry, poised to deliver affordable and environmentally responsible products worldwide.

      As a business-to-business (B2B) company, EFISHient Protein is actively engaging with major fish product manufacturers globally. The company's goal is to scale up production and make their technology accessible at competitive prices, contributing to global food security while preserving marine ecosystems.

      About EFISHient Protein:

      EFISHient Protein is a leading Israeli B2B FoodTech company that is dedicated to accelerating sustainable whitefish meat production efficiently. They aim to provide nutritious, delicious, ethical, and affordable solutions that can be enjoyed by everyone.

      Leveraging their unique expertise in white fish science along with alternative protein industry know-how, EFISHient Protein develops a pioneering cultivated whitefish meat production system. This system is designed to be utilized by food manufacturers and food service industries across the globe, revolutionizing the way white fish meat is produced and consumed.

      Photo: https://mma.prnewswire.com/media/2381451/EFISHient_Protein.jpg

      For media inquiries or further information, please contact Rotem Alon at [email protected]

      SOURCE EFISHient Protein

      Modal title

      Contact PR Newswire

      • +972-77-2005042
        from 8 AM - 11 PM IL

      Global Sites

      • APAC
      • APAC - Traditional Chinese
      • Asia
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany

       

      • India
      • Indonesia
      • Israel
      • Italy
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland

       

      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921
      Global Sites
      • Asia
      • Brazil
      • Canada
      • Csezh
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Israel
      • Italie
      • Mexico
      • Middle East
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States
      +972-77-2005042
      from 8 AM - 11 PM IL
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • Cookie Settings
      Copyright © 2026 Cision US Inc.